Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
نویسندگان
چکیده
منابع مشابه
Preliminary Results of Allogenic Hematopoietic Stem Cell Transplantation of non-M3 Acute Myeloid Leukemia
Background: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) is used as treatment of choice for patients with acute myeloid leukemia (AML). We aimed to evaluate the prognostic factors in 2-year overall survival of patients with non-M3 AML who underwent allogenic HSCT. Methods: This is a Cross sectional retrospective study. Demographic data and study of variables such as age...
متن کاملpreliminary results of allogenic hematopoietic stem cell transplantation of non-m3 acute myeloid leukemia
background: allogeneic hematopoietic stem cell transplantation (allo-hsct) is used as treatment of choice for patients with acute myeloid leukemia (aml). we aimed to evaluate the prognostic factors in 2-year overall survival of patients with non-m3 aml who underwent allogenic hsct. methods: this is a cross sectional retrospective study. demographic data and study of variables such as age, sex,...
متن کاملBrachial Plexopathy due to Myeloid Sarcoma in a Patient With Acute Myeloid Leukemia After Allogenic Peripheral Blood Stem Cell Transplantation
Myeloid sarcoma is a solid, extramedullary tumor comprising of immature myeloid cells. It may occur in any organ; however, the invasion of peripheral nervous system is rare. Herein, we report the case of myeloid sarcoma on the brachial plexus. A 37-year-old woman with acute myelogenous leukemia achieved complete remission after chemotherapy. One year later, she presented right shoulder pain, pr...
متن کاملStem cell transplantation for chronic myeloid leukemia in children.
Hematopoietic stem cell transplantation (SCT) is the only proven cure for chronic myeloid leukemia (CML), a rare disease in childhood. We report outcomes of 314 children with Philadelphia-chromosome-positive (Ph+) CML undergoing SCT from HLA-matched siblings (n = 182) or volunteer-unrelated donors (VUD; n = 132). Three-year overall survival (OS) and leukemia-free survival (LFS) rates were 66% a...
متن کامل[Allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia].
Cármino A. de Souza1 Allogeneic Stem Cell Transplantation (ASCT) remains the unique curative therapy for CML in all clinical phases of the disease. However, the results of Imatinib Mesilate (IM) therapy are sufficiently impressive to have displaced ASCT to secondor thirdline treatment depending on the availability of newly developed tyrosine kinase inhibitors. The decision for transplantation d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Hematology
سال: 2018
ISSN: 2090-6560,2090-6579
DOI: 10.1155/2018/2045985